5/8/14: Metabolic Complications in HIV


By Daniel Lee, MD

Downloads and Links


    • Slideset:  download
    • Lipid Management in Patients Who Have HIV and Are Receiving
      HIV Therapy:
    • Diagnosis, Prediction, and Natural Course of HIV-1 Protease-inhibitor Associated Lipodystrophy, Hyperlipidaemia, and Diabetes Mellitus:  download
    • Preliminary Guidelines for the Evaluation and Management of Dyslipidemia
      in Adults Infected with Human Immunodeficiency Virus and Receiving
      Antiretroviral Therapy: Recommendations of the Adult AIDS:
    • Effects of Tesamorelin, a Growth Hormone–Releasing
      Factor, in HIV-Infected Patients With Abdominal Fat
      Accumulation: A Randomized Placebo-Controlled
      Trial With a Safety Extension:
    • Efficacy and Safety of Tenofovir DF
      vs Stavudine in Combination Therapy
      in Antiretroviral-Naive Patients:
    • HIV–Associated Lipodystrophy:
      Pathogenesis, Prognosis, Treatment,
      and Controversies:
    • Hyperlactatemia and Hepatic Abnormalities in 10 Human Immunodeficiency
      Virus–Infected Patients Receiving Nucleoside Analogue Combination Regimens:
    • Management of Metabolic Complications Associated With
      Antiretroviral Therapy for HIV-1 Infection: Recommendations
      of an International AIDS Society–USA Panel:
    • Tenofovir Disoproxil Fumarate in Nucleoside-Resistant HIV-1 Infection:  download
    • Guidelines for the Use of Antiretroviral Agents in
      HIV-1-Infected Adults and Adolescents: